Multidrug-resistant tuberculosis (MDR-TB) is a form of tuberculosis that occurs due to a strain of Mycobacterium tuberculosis that is resistant to at least isoniazid and rifampicin with or without any other first-line
antitubercular drugs.
2 mL was inoculated into four tubes of Lowenstein-Jensen (LJ) medium each, containing potassium nitrate (1000 [micro]g/mL) &
antitubercular drugs of specific concentration.
Sputum smear-negative tuberculosis was diagnosed on the basis of clinical symptomatology, chest X-ray findings, raised ESR and response to
antitubercular chemotherapy.
Common drugs associated are cotrimoxazole, nevirapine and
antitubercular drugs.
As per the RNTCP guidelines, category I
antitubercular treatment was started.
Treatment: Patients with TB pleural effusion were treated with
Antitubercular treatment.
Definite clinical and radiological improvement in 6 to 8 weeks after administration of
antitubercular treatment.
This study included adults diagnosed and referred by collaborating department of treated pulmonary TB patients having completed Category I full course of
antitubercular treatment [2[(EHRZ).
In these cases, MDR-TB shows additional resistance to the second-line
antitubercular drugs.
She has been diagnosed with pulmonary tuberculosis (TB) and been on
antitubercular treatment for over a month.
Effect of rifampicin-based
antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosis.
Biochemical studies on the plant methanolic, hexane and aqueous extracts show the presence of the quinoline alkaloid lunacridine to be effective against tropical ulcers [16],
antitubercular [14] and antibacterial activity [17,18], graveolinine, 4-methoxy-2-phenylquinoline and kokusagine for antituberculosis activity [19], lunacridine and its trifluoroacetyl derivative for DNA intercalation, topoisomerase II decatenation, cytotoxicity and caspase activation activities [16] and Cytochrome P450 2D6 inhibitory effect [20].
